We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTM:NYSEWhite Mountains Insurance Group, Ltd. Analysis

Data as of 2026-09-04 - not real-time

$2,103.49

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

White Mountains Insurance Group, Ltd. trades at $2,103.49, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have lost 4.7%. Momentum indicators put RSI at 44.3 (neutral) with MACD reading bearish. Price has been bracketed by support at $2,073.35 and resistance at $2,172.18.
On valuation the read is undervalued — earnings multiple of 4.8 versus a 16.5 sector average, below the peer group. Revenue is growing at 22.5% on a 37.7% profit margin. The 0.05% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 14.8%, a beta of 0.13 and a maximum drawdown of 14.2%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 7 out of 10.

Top Market Events

Bermuda-domiciled White Mountains Insurance Group earned second quarter 2026 net income of $199.HANOVER, N.H. AP — HANOVER, N.H. AP — White Mountains Insurance Group Ltd. WTM on Thursday reported net income of...seattlepi.com29dWhite Mountains: Q2 Earnings SnapshotHANOVER, N.H. AP — HANOVER, N.H. AP — White Mountains...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 2124.62
  • MACD momentum is negative
  • RSI at 44.3 is in neutral territory

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 4.8 versus sector average of 16.5
  • Trading below the 200-day average of 2124.62
  • MACD momentum is negative

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 4.8 versus sector average of 16.5
  • Profit margin of 37.7% is healthy
  • Revenue growth of +22.5%

Key Metrics & Analysis

Financial Health

Revenue Growth22.50%
Profit Margin37.66%
P/E Ratio4.8
ROE20.36%
ROA3.55%
Debt/Equity14.91
P/B Ratio1.0
Op. Cash Flow$388.2M
Free Cash Flow$687.0M
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI44.3
Support$2,073.35
Resistance$2,172.18
MA 20$2,121.35
MA 50$2,140.78
MA 200$2,124.62
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair Value$9,108.85
GradeUndervalued
TypeBlend
Dividend Yield0.05%

Risk Assessment

Beta0.13
Volatility14.77%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.